BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 37030308)

  • 1. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel risk prediction algorithm to estimate 10-year risk of oesophageal cancer in primary care: prospective cohort study and evaluation of performance against two other risk prediction models.
    Hippisley-Cox J; Mei W; Fitzgerald R; Coupland C
    Lancet Reg Health Eur; 2023 Sep; 32():100700. PubMed ID: 37635924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2015 Sep; 5(9):e008503. PubMed ID: 26353872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ Open; 2014 Aug; 4(8):e005809. PubMed ID: 25168040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
    Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
    EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting risk of emergency admission to hospital using primary care data: derivation and validation of QAdmissions score.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2013 Aug; 3(8):e003482. PubMed ID: 23959760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2015 Nov; 351():h5441. PubMed ID: 26560308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
    Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
    Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Jun; 357():j2497. PubMed ID: 28620089
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
    Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M
    Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2015 Mar; 5(3):e007825. PubMed ID: 25783428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of first-time traumatic anterior shoulder dislocation: the UK TASH-D cohort study.
    Rees JL; Shah A; Edwards K; Sanchez-Santos MT; Robinson DE; Delmestri A; Carr A; Arden N; Lamb SE; Rangan A; Judge A; Pinedo-Villanueva R; Holt T; Hopewell S; Prieto-Alhambra D; Collins G
    Health Technol Assess; 2019 Apr; 23(18):1-104. PubMed ID: 31043225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
    Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
    Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Sep; 358():j4208. PubMed ID: 28931509
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm.
    Hippisley-Cox J; Coupland C
    Br J Gen Pract; 2021 May; 71(706):e364-e371. PubMed ID: 33875417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
    PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study.
    Archer L; Koshiaris C; Lay-Flurrie S; Snell KIE; Riley RD; Stevens R; Banerjee A; Usher-Smith JA; Clegg A; Payne RA; Hobbs FDR; McManus RJ; Sheppard JP;
    BMJ; 2022 Nov; 379():e070918. PubMed ID: 36347531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.